A carregar...
Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia
CD200, formerly known as OX-2, is a type I glycoprotein that is expressed on a variety of cell types. CD200 has been shown to be overexpressed in chronic lymphocytic leukemia (CLL). Although previous studies have confirmed the diagnostic value of CD200 in differentiating CLL from to other B-cell chr...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4924660/ https://ncbi.nlm.nih.gov/pubmed/26910908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6948 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|